ATPC earnings analysis
What we found in ATPC's 10-Q: the parts that mattered, the offsets in the same document, and what the company said about what comes next.
Our reading of the filing · Free to read, no account needed
The extracted filing text does not include the June 30, 2026 income statement, balance sheet, cash-flow statement, segment disclosures, or MD&A financial discussion, so current-period revenue, margins, EPS, cash flow and working-capital trends cannot be quantified. The principal disclosure is a high-severity control issue: management concluded controls were not effective as of June 30, 2026 and identified 3 material weaknesses. Remediation is planned, including consulting support and employee training, with implementation anticipated by the end of fiscal year 2026; no numeric operating guidance was provided.
The parts that mattered.
Pulled out of the filing itself, with the figures the company reported.
- Internal Control Remediation Planned
- Management plans to engage a consulting firm specializing in compliance and internal controls as a temporary remediation measure, and plans additional employee training on U.S. GAAP and internal controls.
- Remediation Target Set
- Management anticipates that the remediation initiatives will be at least partially, if not fully, implemented by the end of fiscal year 2026.
And the other side of it.
The offsets in the same document — the things a summary that only listed the good news would have left out.
- Disclosure Controls Not Effective
- As of June 30, 2026, the CEO and CFO concluded that disclosure controls and procedures were not effective at the reasonable assurance level, creating risk of untimely detection of material misstatements.
- Three Material Weaknesses
- Management identified 3 material weaknesses as of December 31, 2025: insufficient accounting personnel, no functional internal audit capability, and insufficient procedures to assess third-party manager credit risk before investment decisions.
- Unhedged Foreign Exchange Exposure
- The company has not hedged its foreign-currency exposures, while revenues are primarily denominated in Malaysian Ringgit and expenses include Malaysian Ringgit, U.S. dollars, Chinese Yuan and Hong Kong dollars.
What they said about what is next.
No quantitative revenue or EPS outlook was provided in the extracted filing text. Management stated that remediation initiatives are anticipated to be at least partially, if not fully, implemented by the end of fiscal year 2026.
The filing reads about the same as the one before it.
What came before.
- 10-Q · May 15, 2026
- Agape ATP Corporation reported revenue of $399,133 for Q4 2025, a decline of 5.3% from the prior year, with a gross margin improving to 58.6%. EPS came in at -0.35, showing significant operational losses despite reduced…
- 10-K · April 13, 2026
- Agape ATP Corporation is a Malaysia-focused health & wellness direct-selling company that reported revenue of $399,133 (actual) with EPS of -0.35 for the reported period. The company has a large distributor/member base…
- 10-Q · November 13, 2025
- Agape ATP reported Q3 2025 revenue of $370,593 (up from $331,289 in Q3 2024) and gross profit of $239,103, while GAAP loss per share improved to $(0.01). The company remains unprofitable with an operating loss of…
- 10-Q · May 15, 2025
- Agape ATP reported revenue of $289,037 for the quarter ended March 31, 2025, down from $318,643 a year earlier (−$29,606 or −9.3%), while GAAP loss per share improved to $(0.07) from $(0.18) in the prior-year quarter.…
This is our reading of a public filing, not the filing. Read the original on SEC.gov · Educational only. Nothing here is investment advice.
Read the next one first.
We read every filing ATPC makes the day it lands, and put it next to what the options market did about it. Members get both, and an alert when a filing arrives.
Cancel anytime · Month to month · Switch tiers whenever